Editorial
Treatment of rest-activity disorders in dementia and special focus on sundowning
Jürgen Staedt,
Gabriela Stoppe,
Corresponding Author
Jürgen Staedt
Department of Psychiatry, Vivantes Klinikum Berlin-Spandau, Germany
Department of Psychiatry, Vivantes Klinikum Berlin-Spandau, Germany.Search for more papers by this authorGabriela Stoppe
Psychiatric University Hospital, Basel, Switzerland
Search for more papers by this authorJürgen Staedt,
Gabriela Stoppe,
Corresponding Author
Jürgen Staedt
Department of Psychiatry, Vivantes Klinikum Berlin-Spandau, Germany
Department of Psychiatry, Vivantes Klinikum Berlin-Spandau, Germany.Search for more papers by this authorGabriela Stoppe
Psychiatric University Hospital, Basel, Switzerland
Search for more papers by this author
REFERENCES
- Aarsland D, Laake K, Larsen JP, et al. 2002. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72: 708–712.
- Ancoli-Israel S, Kripke DF. 1989. Now I lay me down to sleep: the problem of sleep fragmentation in the elderly and demented residents of nursing homes. Bull Clin Neurosci 1154: 127–132.
- Ancoli-Israel S, Martin JL, Gehrman P, et al. 2003. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 11: 194–203.
- Asayama K, Yamadera H, Ito T, et al. 2003. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70: 334–341.
- Barinaga M. 1997. How jet-lag hormone does double duty in the brain. Science 277: 480.
- Basseti C, Aldrich MS, Chervin RD, et al. 1996. Sleep apnea in patients with transient ischemic attack and stroke. Neurology 47: 1167–1173.
- Belenky MA, Pickard GE. 2001. Subcellular distribution of 5-HT(1B) and 5-HT (7) receptors in the mouse suprachiasmatic nucleus. Comp Neurol 432: 371–388.
- Black S, Roman GC, Geldmacher DS, et al. 2003. Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 34(10): 2323–2330.
- Bliwise DL. 1994. What is sundowning? J Am Geriatr Soc 42: 1009–1011.
- Bliwise DL, Hughes M, McMahon PM, et al. 1995. Observed sleep/wakefulness and severity of dementia in an Alzheimer's diesease special care unit. J Gerontol A Biol Sci Med Sci 50: 303–306.
- Bliwise DL, Adelman CL, et al. 2004. Polysomnographic correlates of spontaneous nocturnal wetness episodes in incontinent geriatric patients. Sleep 27: 153–157.
- Bullock R. 2004. Cholinesterase inhibitors and vascular dementia: another string to their bow? CNS Drugs 18: 79–92.
- Burgio LD, Scilley K, Hardin M, Hsu C. 2001 Temporal patterns of disruptive vocalization in elderly nursing home residents. Int J Geriatr Psychiatry 16: 378–386.
- Burns A, Spiegel R, Quarg P. 2004. Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease. Int J Geriatr Psychiatry 19: 243–249.
- Cacabelos R, Rodriguez B, Carrera C, et al. 1996. APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 18: 693–706.
- Cardinali DP, Brusco LI, Liberczuk C, et al. 2002. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 23: 20–23.
- Coen RF, Swanwick GR, O'Boyle CA, et al. 1997. Behaviour disturbance and other predictors of carer burden Alzheimer's disease. Int J Geriatr Psychiatry 12: 331–336.
10.1002/(SICI)1099-1166(199703)12:3<331::AID-GPS495>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- Erkinjuntti T, Kurz A, Gauthier S, et al. 2002. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 359: 1283–1290.
- Evans LK. 1987. Sundown syndrome in institutionalized elderly. J Am Geriatr Soc 35: 101–108.
- Feldman H, Gauthier S, Hecker J, et al. 2001. Donepezil MSAD Study Investigators Group: a 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57: 613–620.
- Feldman H, Gauthier S, Hecker J, et al. 2003. Donepezil MSAD Study Investigators Group: efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc 51: 737–744.
- Foley DJ, Monjan AA, Brown SL, et al. 1995. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18: 425–432.
- Gallagher-Thompson D, Brooks JO III, et al. 1992. The relations among caregiver stress, ‘sundowning’ symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc 40: 807–810.
- Gasio PF, Kräuchli K, Cajochen C, et al. 2003. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Experiment Gerontol 38: 207–216.
- Graessel E. 2000. Warum pflegen Angehörige? Ein Pflegemodell für die häusliche Pflege im höheren Lebensalter. Zschr Gerontopsychol Psychiatr 13: 85–94.
10.1024//1011-6877.13.2.85 Google Scholar
- Haffmans PM, Sival RC, Lucius SA, et al. 2001. Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study. Int J Geriatr Psychiatry 16: 106–110.
- Jelicic M, Bosma H, Ponds RW, et al. 2002. Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Ageing Study (MAAS). Int J Geriatr Psychiatry 17: 73–77.
- Jin X, von Gall C, Pieschl RL, et al. 2003. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 23: 1054–1060.
- Kumar AM, Tims F, Cruess DG, et al. 1999. Music therapy increases melatonin levels in patients with Alzheimer's disease. Altern Ther Health Med 5: 49–57.
- Kurz AF, Erkinjuntti T, Small GW, et al. 2003. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. Eur J Neurol 10: 633–640.
- Lavie P. 1997. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 12: 627–665.
- Liu C, Weaver DR, Jin X, et al. 1997. Molecular dissection of two distinct actions of melatonin on suprachiasmatic circadian clock. Neuron 19: 91–102.
- Lyketsos CG, Lindell Veiel L, Baker A, et al. 1999. A randomized, controlled trail of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry 14: 520–525.
10.1002/(SICI)1099-1166(199907)14:7<520::AID-GPS983>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- Madeira MD, Pereira PA, Silva SM, et al. 2004. Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus. Neuroscience 125: 889–901.
- Malouf R, Birks J. 2004. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev ( 1): CD004395.
- Martin J, Marler M, Shochat T, et al. 2000. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol Int 17: 405–418.
- McCurry SM, Gibbons LE, Logsdon RG, et al. 2003. Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project. J Am Geriatr Soc 51: 1455–1460.
- McGeer PL, McGeer EG, Suzuki J, et al. 1984. Aging, Alzheimer's disease, and the cholinergic systen of the basal forebrain. Neurology 34: 741–745.
- McKeith IG, Grace JB, Walker Z, et al. 2000. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 15: 387–392.
10.1002/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- Miller JD. 1993. On the nature of the circadian clock in mammals. Am J Physiol 264: 821–832.
- Mishima K, Okawa M, Shimizu T, et al. 2001. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metabol 86: 129–134.
- Moretti R, Torre P, Antonello RM, et al. 2003. Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 18(5): 265–272.
- Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. 2001. Pathological correlates of late-onset dementia in a multicentre, community-based population in Englang and Wales. Lancet 357: 169–175.
- Nunez A. 1996. Unit activity of rat basal forebrain neurons: relationship to cortical activity. Neuroscience 72: 757–766.
- Okumoto Y, Koyama E, Matsubara H, et al. 1998. Sleep improvement by light in a demented aged individual. Psychiatry Clin Neurosci 52: 194–196.
- Pollak CP, Perlick D, Linsner JP, et al. 1990. Sleep problem in the community elderly as predictors of death and nursing home placement. J Commun Hlth 15: 123–135.
- Pollak CP, Stokes PE. 1997. Circadian rest-activity rhythms in demented and nondemented older community residents and their caregivers. J Am Geriatr Soc 45: 446–452.
- Reinikainen KJ, Riekkinen PJ, Paljärvi L, et al. 1988. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13: 135–146.
- Riekkinen J Jr, Sirviö J, Riekkinen P. 1990. Relation between EEG delta power and the cortical choline acetyltransferase content. Neurosci Res 8: 12–20.
- Samuel W, Caligiuri M, Galasko D, et al. 2000. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 15: 794–802.
- Satlin A, Volicer L, Ross V, et al. 1992. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 149: 1028–1032.
- Serfaty M, Kennell-Webb S, Warner J, et al. 2002. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 17: 1120–1127.
- Shochat T, Martin J, Marler M, et al. 2000. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 9: 373–337.
- Staedt J, Stoppe G. 2004. Are sleep and its disorders of interest for psychiatric and psychosomatic medicine? In Advances in Psychosomatic Medicine, A Diefenbacher (ed.), Vol. 26. Karger: Basel; 1–6.
- Steriade M. 2004. Acetylcholine systems and rhythmic acticities during the waking-sleep cycle. Prog Brain Res 145: 179–196.
- Stoppe G, Brandt C, Staedt J. 1999. Behavioural problems associated with dementia: the role of newer antipsychiotics. Drugs & Aging 14: 41–54.
- Tractenberg RE, Singer CM, Cummings JL, et al. 2003. The sleep disorders inventory: an instrument for studies of sleep disturbance in persons with alzheimers disease. J Sleep Res 12: 331–337.
- Teri L, Logsdon RG, McCurry SM. 2002. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am 86: 641–656.
- Trinh NH, Hoblyn J, Mohanty S, et al. 2003. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. J Am Med Ass 289: 210–216.
- Van Someren EJW, Hagebeuk EEO, Lijzenga C, et al. 1996. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 40: 259–270.
- Van Someren EJ, Kessler A, Mirmiran M, et al. 1997. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 41: 955–963.
- Volicer L, Harper DG, Manning BC, et al. 2001. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158: 704–711.
- Wilkinson D, Doody R, Helme R, et al. 2003. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 26;61(4): 479–486.
10.1212/01.WNL.0000078943.50032.FC Google Scholar
- Wenk GL. 1997. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Memory 67: 85–95.
- Werth E, Savaskan E, Knoblauch V, et al. 2002. Decline in long-term circadian rest-activity cycle organization in a patient with dementia. J Geriatr Psychiatry Neurol 15: 55–59.
- Wu YH, Feenstra MG, Zhou JN, et al. 2003. Molecular changes underlying reduced pineal melatonin levels in Alzheimer's disease: alterations in preclinical und clincal stages. J Clin Endocrinol Metab 88: 5898–5906.
- Yoon IY, Kripke DF, Elliott JA, et al. 2003. Age-related changes of circadian rhythms and sleep-wake cycles. Am Geriatr Soc 51: 1085–1091.
- Yuen EJ, Zisselman MH, Louis DZ, et al. 1997. Sedative-hypnotic use by the elderly: effects on hospital length of stay and costs. J Ment Hlth Administr 24: 90–97.
